WILLIAM CLEVER: Open Payments
NPI 1982608758 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,793 in 161 payments from 25 companies in 2025. Trend: 2023 $2,040 · 2024 $2,869 · 2025 $2,793
Food & beverage: $2,793
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $526 |
| Otsuka America Pharmaceutical, Inc. | 18 | $302 |
| Novo Nordisk Inc | 18 | $271 |
| Lundbeck LLC | 15 | $232 |
| Axsome Therapeutics, Inc. | 10 | $169 |
| Vanda Pharmaceuticals Inc. | 11 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $132 |
| Lilly USA, LLC | 9 | $132 |
| UCB, Inc. | 3 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
Products named: REXULTI, UBRELVY, HETLIOZ, VRAYLAR, Ozempic, QULIPTA, Kerendia, Auvelity.
Industry payments across TN — which companies pay providers there.
